- Home
- PSTV vs ATNF Comparison
PSTV vs ATNF Comparison
Compare PSTV & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- ATNF
- Stock Information
- Founded
- PSTV 1996
- ATNF 2016
- Country
- PSTV United States
- ATNF United States
- Employees
- PSTV N/A
- ATNF N/A
- Industry
- PSTV Medical/Dental Instruments
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- PSTV Health Care
- ATNF Health Care
- Exchange
- PSTV Nasdaq
- ATNF Nasdaq
- Market Cap
- PSTV 6.3M
- ATNF 5.7M
- IPO Year
- PSTV N/A
- ATNF N/A
- Fundamental
- Price
- PSTV $1.22
- ATNF $1.50
- Analyst Decision
- PSTV Strong Buy
- ATNF
- Analyst Count
- PSTV 2
- ATNF 0
- Target Price
- PSTV $13.50
- ATNF N/A
- AVG Volume (30 Days)
- PSTV 34.6K
- ATNF 1.1M
- Earning Date
- PSTV 03-04-2025
- ATNF 02-13-2025
- Dividend Yield
- PSTV N/A
- ATNF N/A
- EPS Growth
- PSTV N/A
- ATNF N/A
- EPS
- PSTV N/A
- ATNF N/A
- Revenue
- PSTV $5,725,000.00
- ATNF N/A
- Revenue This Year
- PSTV $32.12
- ATNF N/A
- Revenue Next Year
- PSTV N/A
- ATNF $54.15
- P/E Ratio
- PSTV N/A
- ATNF N/A
- Revenue Growth
- PSTV 52.63
- ATNF N/A
- 52 Week Low
- PSTV $0.93
- ATNF $1.16
- 52 Week High
- PSTV $2.67
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- PSTV 52.68
- ATNF 38.17
- Support Level
- PSTV $1.16
- ATNF $1.40
- Resistance Level
- PSTV $1.24
- ATNF $1.67
- Average True Range (ATR)
- PSTV 0.08
- ATNF 0.15
- MACD
- PSTV 0.01
- ATNF 0.00
- Stochastic Oscillator
- PSTV 48.00
- ATNF 11.11
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.